Oragenics (OGEN) News Today $0.28 -0.01 (-2.99%) (As of 02:45 PM ET) Add Compare Share Share Headlines Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Oragenics, Inc. to Present at The Centurion One Capital 2nd Annual Bahamas SummitOctober 18, 2024 | globenewswire.comOragenics inks sales agreement for at-the-market stock offeringOctober 17, 2024 | investing.comBioMedNewsBreaks — Oragenics, Inc. (NYSE American: OGEN) Reports on Lead Candidate Drug Development, ‘Urgency’ to Advance First-in-Class Concussion TreatmentOctober 9, 2024 | msn.comOragenics, Inc. Updates Shareholders on Concussion Drug Progress and Phase II Trial PreparationOctober 9, 2024 | globenewswire.comInvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Advances Concussion Treatment with Promising Study for Nasal Spray Drug ONP-002October 8, 2024 | msn.comEXCLUSIVE: Oragenics Completes Key FDA-Recognized Study For Concussion Drug CandidateOctober 8, 2024 | benzinga.comOragenics Inc. Successfully Completes Key FDA-Recognized Study for ONP-002October 8, 2024 | globenewswire.comCore One Labs Inc. (LD6.F) Stock Price, News, Quote & History - Yahoo FinanceSeptember 23, 2024 | finance.yahoo.comOragenics, Inc. Announces Closing of Public OfferingSeptember 5, 2024 | globenewswire.comBioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Enters into Public Offering Agreement Estimated to Total $4.45MSeptember 4, 2024 | msn.comWhy Oragenics (OGEN) Stock Is Getting HammeredSeptember 4, 2024 | benzinga.comOragenics, Inc. Announces Pricing of Public OfferingSeptember 4, 2024 | globenewswire.comOragenics (AMEX:OGEN) Stock Quotes, Forecast and News SummaryAugust 25, 2024 | benzinga.comInvestorNewsBreaks – Oragenics Inc. (NYSE American: OGEN) Completes Manufacture, Filling of Intranasal Device for Use in Upcoming Clinical TrialAugust 21, 2024 | msn.comEXCLUSIVE: Oragenics Completes Spray Dry Drug Manufacturing, Intranasal Device Filling For Anticipated Mid-Stage Study For Patients With Brain InjuryAugust 21, 2024 | msn.comOragenics Inc. Completes Spray Dry Drug Manufacturing and Intranasal Device Filling in Anticipation of Phase IIa Clinical Trial in Concussed PatientsAugust 21, 2024 | globenewswire.comBioMedNewsBreaks — Oragenics Inc. (NYSE American: OGEN) Reports on Status of Lead Drug Candidate Designed to Treat ConcussionAugust 19, 2024 | msn.comOragenics, Inc. Provides Update on its Drug Intended to Treat Concussion and Non-Compliance with NYSE American Continued Listing StandardsAugust 16, 2024 | globenewswire.comOragenics Inc. Shows Concussion Drug, ONP-002, Designed for Acute Field-Delivery Stable Across a Wide Temperature RangeAugust 14, 2024 | globenewswire.comOragenics, Inc. Announces Concussion Drug Successfully Completes FDA-Required Genotoxicity StudyAugust 12, 2024 | globenewswire.comEXCLUSIVE: Oragenics' Concussion Drug Clears FDA-Required Cardiotoxicity Testing, Planning For Phase II Trials UnderwayAugust 8, 2024 | msn.comOragenics Inc. Announces Concussion Drug, ONP-002, Successfully Clears FDA-Required Cardiotoxicity TestingAugust 8, 2024 | globenewswire.comOGEN Stock Earnings: Oragenics Reported Results for Q4 2023June 28, 2024 | investorplace.comOragenics Develops Automated Intranasal Device for Treating Concussed PatientsJune 27, 2024 | globenewswire.comOragenics, Inc. Announces Closing of Public OfferingJune 26, 2024 | globenewswire.comOragenics, Inc. Announces Pricing of Public OfferingJune 25, 2024 | globenewswire.comOragenics, Inc. Announces Proposed Public OfferingJune 24, 2024 | globenewswire.comOragenics Appoints William “Frank” Peacock MD as Chief Clinical OfficerMay 22, 2024 | globenewswire.comOragenics, Inc. to Host Webinar Panel on Neurotrauma MedicineMay 17, 2024 | globenewswire.comOragenics climbs 9% amid Phase 2 study, business updatesMay 16, 2024 | msn.comOragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion TrialMay 16, 2024 | finance.yahoo.comOGEN Stock Earnings: Oragenics Reported Results for Q1 2024May 16, 2024 | investorplace.comOragenics, Inc. (OGEN)May 11, 2024 | finance.yahoo.comOragenics partners with Avance Clinical for Phase 2 concussion studyMay 7, 2024 | msn.comOragenics Partners with Avance Clinical for Phase II Concussion Trial in AustraliaMay 7, 2024 | finance.yahoo.comOragenics, Inc. (OGEN) Stock Price, News, Quote & History - Yahoo FinanceApril 27, 2024 | finance.yahoo.comOdyssey Health, Inc. (ODYY)April 20, 2024 | finance.yahoo.comOragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing StandardsApril 19, 2024 | businesswire.comOragenics IncApril 17, 2024 | money.usnews.comOragenics, Inc. (OGEN) Latest Stock News & Headlines - Yahoo FinanceApril 16, 2024 | ca.finance.yahoo.comOragenics, Inc. Files 10K and Provides Company UpdateApril 1, 2024 | finance.yahoo.comOragenics Appoints Kelly As Chief Medical OfficerMarch 18, 2024 | markets.businessinsider.com15 Highest Quality Probiotics For Gut HealthMarch 17, 2024 | finance.yahoo.comOragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat ConcussionMarch 5, 2024 | businesswire.comOragenics Announces Closing of Public OfferingMarch 1, 2024 | businesswire.comOragenics announces public stock offeringMarch 1, 2024 | uk.investing.comWhy Is Oragenics (OGEN) Stock Down 45% Today?February 28, 2024 | investorplace.comOragenics Prices Public Offering Of 1.40 Mln Shares At $1.50/shr; Stock PlungesFebruary 27, 2024 | markets.businessinsider.comOragenics Announces Pricing of Public OfferingFebruary 27, 2024 | businesswire.comOragenics Shares Fall After Proposed Public OfferingFebruary 27, 2024 | marketwatch.com Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Trump’s Sending THIS Crypto Higher on Purpose (Ad)Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW OGEN Media Mentions By Week OGEN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. OGEN News Sentiment▼0.000.47▲Average Medical News Sentiment OGEN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. OGEN Articles This Week▼01▲OGEN Articles Average Week Get Oragenics News Delivered to You Automatically Sign up to receive the latest news and ratings for OGEN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Sol-Gel Technologies News Today AIM ImmunoTech News Today NLS Pharmaceutics News Today Sensei Biotherapeutics News Today NKGen Biotech News Today Aspira Women's Health News Today Talphera News Today Eagle Pharmaceuticals News Today Turnstone Biologics News Today Indaptus Therapeutics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:OGEN) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oragenics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
